ID
33017
Description
Study ID: 104020 Clinical Study ID: 104020 Study Title: Blinded, randomised study to assess the immunogenicity and safety of GlaxoSmithKline (GSK) Biologicals’ live attenuated measles-mumps-rubella-varicella candidate vaccine when given to healthy children in their second year of life Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00126997 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 4 Study Recruitment Status: Completed Generic Name: Combined Measles, Mumps, Rubella, Varicella Vaccine Trade Name: Priorix Tetra Study Indication: Measles; Mumps; Rubella; Varicella CRF Seiten: 268-336; 870-938
Keywords
Versions (1)
- 11/23/18 11/23/18 -
Copyright Holder
GSK group of companies
Uploaded on
November 23, 2018
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Immunogenicity of Combined Measles, Mumps, Rubella, Varicella Vaccine for healthy 2 y.o children - 104020
Visit 2: Temperature Form
- StudyEvent: ODM
Description
Temperature Log
Description
Episode Number
Data type
text
Description
Temperature
Data type
float
Measurement units
- °C
Description
not taken
Data type
text
Description
If fever, Causality
Data type
boolean
Description
Medical advice
Data type
boolean
Description
Fever Screen
Description
Day
Data type
text
Description
Fever (Axillary ≥ 37.5 °C; Rectal ≥ 38 °C)
Data type
text
Description
If Yes, record Temperature
Data type
float
Measurement units
- °C
Description
Causality
Data type
boolean
Description
Medical Advice
Data type
boolean
Description
Administrative data
Similar models
Visit 2: Temperature Form
- StudyEvent: ODM